Literature DB >> 22896599

Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.

E K Hoebe1, C Wille, E S Hopmans, A R Robinson, J M Middeldorp, S C Kenney, A E Greijer.   

Abstract

Epstein-Barr virus (EBV) BamHI-A rightward frame 1 (BARF1) is considered a major viral oncogene in epithelial cells and has immune-modulating properties. However, in B cells and lymphomas, BARF1 expression is restricted to the viral lytic replication cycle. In this report, the transcriptional regulation of BARF1 during lytic replication is unraveled. Bisulfite sequencing of various cell lines indicated a high level of methylation of the BARF1 gene control region. A BARF1 promoter luciferase reporter construct was created using a CpG-free vector, enabling true assessment of promoter methylation. Induction of the EBV lytic cycle is mediated by the immediate-early proteins BZLF1 (Z) and BRLF1 (R). R was found to activate expression of the BARF1 promoter up to 250-fold independently of Z and unaffected by BARF1 promoter methylation. Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), and specific mutagenesis of the R-responsive elements (RREs) demonstrated direct binding of R to RREs between nucleotides -554 and -327 relative to the BARF1 transcriptional ATG start site. The kinetics of BARF1 expression upon transactivation by R showed that BARF1 mRNA was expressed within 6 h in the context of the viral genome. In conclusion, expression of the BARF1 protein during lytic replication is regulated by direct binding of R to multiple RREs in the gene control region and is independent of the promoter methylation status. The early kinetics of BARF1 upon transactivation by R confirm its status as an early gene and emphasize the necessity of early immune modulation during lytic reactivation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22896599      PMCID: PMC3457140          DOI: 10.1128/JVI.01161-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.

Authors:  J Minarovits; S Minarovits-Kormuta; B Ehlin-Henriksson; K Falk; G Klein; I Ernberg
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

2.  Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.

Authors:  C Liu; N D Sista; J S Pagano
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.

Authors:  Q Tao; K D Robertson; A Manns; A Hildesheim; R F Ambinder
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Establishment and characterization of human gastric carcinoma cell lines.

Authors:  J G Park; H K Yang; W H Kim; J K Chung; M S Kang; J H Lee; J H Oh; H S Park; K S Yeo; S H Kang; S Y Song; Y K Kang; Y J Bang; Y H Kim; J P Kim
Journal:  Int J Cancer       Date:  1997-02-07       Impact factor: 7.396

5.  The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases.

Authors:  A Whitehouse; I M Carr; J C Griffiths; D M Meredith
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Authors:  L D Strockbine; J I Cohen; T Farrah; S D Lyman; F Wagener; R F DuBose; R J Armitage; M K Spriggs
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.

Authors:  H Gruffat; E Manet; A Rigolet; A Sergeant
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

8.  Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.

Authors:  E Flemington; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

9.  Methylation of the Epstein-Barr virus genome in normal lymphocytes.

Authors:  K D Robertson; R F Ambinder
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

10.  Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R.

Authors:  H Gruffat; A Sergeant
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

View more
  11 in total

1.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

2.  BARF1 gene silencing triggers caspase-dependent mitochondrial apoptosis in Epstein-Barr virus-positive malignant cells.

Authors:  Taznim Begam Mohd Mohidin; Ching Ching Ng
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

3.  Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB.

Authors:  Mee Soo Chang; Dong Ha Kim; Jin Kyung Roh; Jaap M Middeldorp; Yang Soo Kim; Sunghan Kim; Seungbong Han; Chul Woo Kim; Byung Lan Lee; Woo Ho Kim; Jun Hee Woo
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 4.  BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.

Authors:  Eveline K Hoebe; Tessa Y S Le Large; Astrid E Greijer; Jaap M Middeldorp
Journal:  Rev Med Virol       Date:  2013-08-31       Impact factor: 6.989

5.  Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.

Authors:  Jürgen Rac; Florian Haas; Andrina Schumacher; Jaap M Middeldorp; Henri-Jacques Delecluse; Roberto F Speck; Michele Bernasconi; David Nadal
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

6.  The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas.

Authors:  Jing Li; Wen Liu; Kui Che; Yan Zhang; Zhenzhen Zhao; Bing Luo
Journal:  Gastroenterol Res Pract       Date:  2017-04-11       Impact factor: 2.260

7.  Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma.

Authors:  Eveline Hoebe; Coral Wille; Stacy Hagemeier; Shannon Kenney; Astrid Greijer; Jaap Middeldorp
Journal:  Cancers (Basel)       Date:  2018-03-17       Impact factor: 6.639

8.  Utility of Serum EB Virus Zta Antibody in the Diagnostic of Nasopharyngeal Carcinoma: Evidences From 2,126 Cases and 15,644 Controls.

Authors:  Guangying Zhang; Zhanzhan Li; Qin Zhou
Journal:  Front Oncol       Date:  2019-12-19       Impact factor: 6.244

9.  Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.

Authors:  Octavia Ramayanti; Hedy Juwana; Sandra A M W Verkuijlen; Marlinda Adham; Michiel D Pegtel; Astrid E Greijer; Jaap M Middeldorp
Journal:  Int J Cancer       Date:  2016-09-23       Impact factor: 7.396

Review 10.  The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.

Authors:  Abigail Morales-Sánchez; Ezequiel M Fuentes-Panana
Journal:  Cancers (Basel)       Date:  2018-03-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.